GT Biopharma (GTBP) had the highest return between February 1, 2017 and April 30, 2017 by a US stock, returning 6,384,968.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 2/1/2017 - 4/30/2017 | 6,384,968.75% |
Avalon GloboCare (ALBT) | 2/1/2017 - 4/30/2017 | 7,794.74% |
SurgePays (SURG) | 2/1/2017 - 4/30/2017 | 1,823.08% |
Medicus Pharma Ltd Common Stock (MDCX) | 2/1/2017 - 4/30/2017 | 1,518.18% |
Ocean Power Technologies (OPTT) | 2/1/2017 - 4/30/2017 | 971.16% |
Datasea (DTSS) | 2/1/2017 - 4/30/2017 | 900% |
Duos Technologies (DUOT) | 2/1/2017 - 4/30/2017 | 475% |
Wetouch Technology Inc Common Stock (WETH) | 2/1/2017 - 4/30/2017 | 440% |
Castellum (CTM) | 2/1/2017 - 4/30/2017 | 375% |
TSS, Inc Common Stock (TSSI) | 2/1/2017 - 4/30/2017 | 350% |
Worksport (WKSP) | 2/1/2017 - 4/30/2017 | 320% |
Pulse Biosciences (PLSE) | 2/1/2017 - 4/30/2017 | 265.45% |
GrabAGun Digital (PEW) | 2/1/2017 - 4/30/2017 | 251.47% |
Galectin Therapeutics (GALT) | 2/1/2017 - 4/30/2017 | 206% |
OLB (OLB) | 2/1/2017 - 4/30/2017 | 200% |
Quantum Computing (QUBT) | 2/1/2017 - 4/30/2017 | 200% |
Atlas Lithium Corporation Common Stock (ATLX) | 2/1/2017 - 4/30/2017 | 200% |
Talos Energy (TALO) | 2/1/2017 - 4/30/2017 | 199.23% |
Quoin Pharmaceuticals Ltd DRC (QNRX) | 2/1/2017 - 4/30/2017 | 192.11% |
Oncolytics Biotech (ONCY) | 2/1/2017 - 4/30/2017 | 180.49% |
Opus Genetics (IRD) | 2/1/2017 - 4/30/2017 | 152.94% |
RTB Digital (RTB) | 2/1/2017 - 4/30/2017 | 150% |
DiaMedica Therapeutics (DMAC) | 2/1/2017 - 4/30/2017 | 134.47% |
TG Therapeutics (TGTX) | 2/1/2017 - 4/30/2017 | 127.84% |
AGIG (AGIG) | 2/1/2017 - 4/30/2017 | 126.32% |